We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Lung Plug System Prevents Postbiopsy Pneumothorax

By HospiMedica International staff writers
Posted on 09 Jan 2013
A lung-biopsy tract plug allows physicians to apply a special hydrogel to the needle entrance site, blocking air from exiting through the hole.

The Bio-Seal Lung Biopsy Tract Plug system is a single use disposable device intended for the prevention of pneumothorax following percutaneous lung biopsy. More...
The system is composed of a syringe, prefilled with a hydrogel that has been solidified and then dried, that is attached to a stylet. After the biopsy sample is removed, the physician attaches the system to the needle used to access the biopsy site and injects the hydrogel through the stylet into the empty space left by the removed lung tissue.

The dried hydrogel rehydrates and expands on contact with body fluids to fill the space, creating a seal that prevents air from leaking out of the lung. The hydrogel is absorbed into the body after healing of the puncture site has occurred. Each Bio-Seal system features two sets of plugs and coaxial adaptors to accommodate multiple lung biopsy sites. The Bio-Seal Lung Biopsy Tract Plug system is a product of Angiotech (Vancouver, Canada), and is available in a broad range of 19G introducers, which may be used in conjunction with any 20G or 22G biopsy device.

“This is an innovative new use for an existing device that can help make percutaneous transthoracic needle lung biopsies safer,” said Christy Foreman, director of the office of device evaluation at the US Food and drug Administration (FDA) Center for Devices and Radiological Health.

The system reduces the risk of a patient experiencing a pneumothorax during a percutaneous transthoracic needle lung biopsy, occurring when air from the lung leaks into the chest cavity, thus preventing the lungs from expanding properly. The condition can cause chest pain, shortness of breath, and cardiovascular distress, and is particularly dangerous in patients who have lung disease.

Related Links:

Angiotech



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.